ID   ECI2_HUMAN              Reviewed;         394 AA.
AC   O75521; Q5JYK5; Q5JYK7; Q7L124; Q8N0X0; Q9BUE9; Q9H0T9; Q9NQH1;
AC   Q9NYH7; Q9UN55;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-SEP-2009, sequence version 4.
DT   10-MAY-2017, entry version 177.
DE   RecName: Full=Enoyl-CoA delta isomerase 2, mitochondrial;
DE            EC=5.3.3.8;
DE   AltName: Full=DRS-1;
DE   AltName: Full=Delta(3),delta(2)-enoyl-CoA isomerase;
DE            Short=D3,D2-enoyl-CoA isomerase;
DE   AltName: Full=Diazepam-binding inhibitor-related protein 1;
DE            Short=DBI-related protein 1;
DE   AltName: Full=Dodecenoyl-CoA isomerase;
DE   AltName: Full=Hepatocellular carcinoma-associated antigen 88;
DE   AltName: Full=Peroxisomal 3,2-trans-enoyl-CoA isomerase;
DE            Short=pECI;
DE   AltName: Full=Renal carcinoma antigen NY-REN-1;
DE   Flags: Precursor;
GN   Name=ECI2; Synonyms=DRS1, HCA88, PECI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT VAL-344.
RC   TISSUE=Pancreatic islet;
RX   PubMed=10354522; DOI=10.1016/S0925-4439(99)00033-2;
RA   Suk K., Kim Y.-H., Hwang D.-Y., Ihm S.-H., Yoo H.J., Lee M.-S.;
RT   "Molecular cloning and expression of a novel human cDNA related to the
RT   diazepam binding inhibitor.";
RL   Biochim. Biophys. Acta 1454:126-131(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Bone marrow, Skin, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-394 (ISOFORM 1), AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10419495; DOI=10.1074/jbc.274.31.21797;
RA   Geisbrecht B.V., Zhang D., Schulz H., Gould S.J.;
RT   "Characterization of PECI, a novel monofunctional D3,D2-enoyl-CoA
RT   isomerase of mammalian peroxisomes.";
RL   J. Biol. Chem. 274:21797-21803(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-394 (ISOFORM 1), AND VARIANT VAL-344.
RC   TISSUE=Hepatoma;
RX   PubMed=12097419; DOI=10.4049/jimmunol.169.2.1102;
RA   Wang Y., Han K.-J., Pang X.-W., Vaughan H.A., Qu W., Dong X.-Y.,
RA   Peng J.-R., Zhao H.-T., Rui J.-A., Leng X.-S., Cebon J., Burgess A.W.,
RA   Chen W.-F.;
RT   "Large scale identification of human hepatocellular carcinoma-
RT   associated antigens by autoantibodies.";
RL   J. Immunol. 169:1102-1109(2002).
RN   [8]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11256614; DOI=10.1093/embo-reports/kvd058;
RA   Simpson J.C., Wellenreuther R., Poustka A., Pepperkok R., Wiemann S.;
RT   "Systematic subcellular localization of novel proteins identified by
RT   large-scale cDNA sequencing.";
RL   EMBO Rep. 1:287-292(2000).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=15217832; DOI=10.1182/blood-2004-05-1839;
RA   Feng X., Chuhjo T., Sugimori C., Kotani T., Lu X., Takami A.,
RA   Takamatsu H., Yamazaki H., Nakao S.;
RT   "Diazepam-binding inhibitor-related protein 1: a candidate autoantigen
RT   in acquired aplastic anemia patients harboring a minor population of
RT   paroxysmal nocturnal hemoglobinuria-type cells.";
RL   Blood 104:2425-2431(2004).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-51 AND LYS-92, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-119, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-101, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   STRUCTURE BY NMR OF 36-133.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RSGI RUH-045, a human acyl-CoA binding
RT   protein.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 138-394.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of human peroxisomal delta3, delta2 enoyl-CoA
RT   isomerase (pECI).";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Able to isomerize both 3-cis and 3-trans double bonds
CC       into the 2-trans form in a range of enoyl-CoA species. Has a
CC       preference for 3-trans substrates (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: (3Z)-dodec-3-enoyl-CoA = (2E)-dodec-2-enoyl-
CC       CoA.
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Mitochondrion {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Peroxisome matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75521-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75521-2; Sequence=VSP_037854;
CC   -!- TISSUE SPECIFICITY: Abundant in heart, skeletal muscle and liver.
CC       Expressed in CD34(+) T-cells and CD34(+) bone marrow cells.
CC       {ECO:0000269|PubMed:15217832}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the enoyl-CoA
CC       hydratase/isomerase family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-3 is the initiator.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC19317.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAD34173.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAF66247.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH02668.3; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH16781.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAH17474.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAH33841.3; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=AAH34702.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC       Sequence=BAG52068.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF069301; AAC19317.1; ALT_INIT; mRNA.
DR   EMBL; AL136642; CAB66577.1; -; mRNA.
DR   EMBL; AK075108; BAG52068.1; ALT_INIT; mRNA.
DR   EMBL; AL033383; CAI42125.1; -; Genomic_DNA.
DR   EMBL; AL033383; CAI42127.1; -; Genomic_DNA.
DR   EMBL; BC002668; AAH02668.3; ALT_INIT; mRNA.
DR   EMBL; BC016781; AAH16781.1; ALT_INIT; mRNA.
DR   EMBL; BC017474; AAH17474.1; ALT_INIT; mRNA.
DR   EMBL; BC033841; AAH33841.3; ALT_INIT; mRNA.
DR   EMBL; BC034702; AAH34702.1; ALT_INIT; mRNA.
DR   EMBL; AF153612; AAD34173.1; ALT_INIT; mRNA.
DR   EMBL; AF244138; AAF66247.1; ALT_INIT; mRNA.
DR   CCDS; CCDS43420.2; -. [O75521-1]
DR   RefSeq; NP_001159482.1; NM_001166010.1.
DR   RefSeq; NP_006108.2; NM_006117.2.
DR   RefSeq; NP_996667.2; NM_206836.2. [O75521-1]
DR   UniGene; Hs.15250; -.
DR   PDB; 2CQU; NMR; -; A=31-133.
DR   PDB; 2F6Q; X-ray; 1.95 A; A/B/C=138-394.
DR   PDB; 4U18; X-ray; 2.64 A; A/B/C=138-390.
DR   PDB; 4U19; X-ray; 1.88 A; A/B/C=138-390.
DR   PDB; 4U1A; X-ray; 2.85 A; A/B/C=138-384.
DR   PDBsum; 2CQU; -.
DR   PDBsum; 2F6Q; -.
DR   PDBsum; 4U18; -.
DR   PDBsum; 4U19; -.
DR   PDBsum; 4U1A; -.
DR   ProteinModelPortal; O75521; -.
DR   SMR; O75521; -.
DR   BioGrid; 115718; 32.
DR   IntAct; O75521; 12.
DR   MINT; MINT-3001383; -.
DR   STRING; 9606.ENSP00000369461; -.
DR   DrugBank; DB08231; MYRISTIC ACID.
DR   SwissLipids; SLP:000001195; -. [O75521-2]
DR   iPTMnet; O75521; -.
DR   PhosphoSitePlus; O75521; -.
DR   SwissPalm; O75521; -.
DR   BioMuta; ECI2; -.
DR   REPRODUCTION-2DPAGE; IPI00419263; -.
DR   UCD-2DPAGE; O75521; -.
DR   EPD; O75521; -.
DR   MaxQB; O75521; -.
DR   PaxDb; O75521; -.
DR   PeptideAtlas; O75521; -.
DR   PRIDE; O75521; -.
DR   DNASU; 10455; -.
DR   Ensembl; ENST00000380118; ENSP00000369461; ENSG00000198721. [O75521-1]
DR   GeneID; 10455; -.
DR   KEGG; hsa:10455; -.
DR   UCSC; uc003mwd.4; human. [O75521-1]
DR   CTD; 10455; -.
DR   DisGeNET; 10455; -.
DR   GeneCards; ECI2; -.
DR   H-InvDB; HIX0025043; -.
DR   HGNC; HGNC:14601; ECI2.
DR   HPA; HPA022130; -.
DR   HPA; HPA031626; -.
DR   MIM; 608024; gene.
DR   neXtProt; NX_O75521; -.
DR   OpenTargets; ENSG00000198721; -.
DR   PharmGKB; PA33168; -.
DR   eggNOG; KOG0016; Eukaryota.
DR   eggNOG; KOG0817; Eukaryota.
DR   eggNOG; COG1024; LUCA.
DR   eggNOG; COG4281; LUCA.
DR   GeneTree; ENSGT00870000136440; -.
DR   HOVERGEN; HBG006723; -.
DR   InParanoid; O75521; -.
DR   KO; K13239; -.
DR   OMA; SDECMNA; -.
DR   OrthoDB; EOG091G0T5I; -.
DR   PhylomeDB; O75521; -.
DR   TreeFam; TF313375; -.
DR   BioCyc; MetaCyc:HS03615-MONOMER; -.
DR   Reactome; R-HSA-390918; Peroxisomal lipid metabolism.
DR   EvolutionaryTrace; O75521; -.
DR   GeneWiki; PECI_(gene); -.
DR   GenomeRNAi; 10455; -.
DR   PRO; PR:O75521; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000198721; -.
DR   ExpressionAtlas; O75521; baseline and differential.
DR   Genevisible; O75521; HS.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:LIFEdb.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005782; C:peroxisomal matrix; IDA:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:HPA.
DR   GO; GO:0004165; F:dodecenoyl-CoA delta-isomerase activity; IDA:UniProtKB.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; IEA:InterPro.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IEA:Ensembl.
DR   GO; GO:0009062; P:fatty acid catabolic process; IDA:UniProtKB.
DR   Gene3D; 1.10.12.10; -; 1.
DR   Gene3D; 1.20.80.10; -; 1.
DR   InterPro; IPR022408; Acyl-CoA-binding_prot_CS.
DR   InterPro; IPR000582; Acyl-CoA-binding_protein.
DR   InterPro; IPR029045; ClpP/crotonase-like_dom.
DR   InterPro; IPR014748; Crontonase_C.
DR   InterPro; IPR001753; Crotonase_core_superfam.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_3-hlx.
DR   Pfam; PF00887; ACBP; 1.
DR   Pfam; PF00378; ECH_1; 1.
DR   PRINTS; PR00689; ACOABINDINGP.
DR   SUPFAM; SSF47027; SSF47027; 1.
DR   SUPFAM; SSF52096; SSF52096; 1.
DR   PROSITE; PS00880; ACB_1; 1.
DR   PROSITE; PS51228; ACB_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Isomerase; Mitochondrion; Peroxisome; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1     38       Mitochondrion. {ECO:0000255}.
FT   CHAIN        39    394       Enoyl-CoA delta isomerase 2,
FT                                mitochondrial.
FT                                /FTId=PRO_0000214027.
FT   DOMAIN       39    124       ACB. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00573}.
FT   REGION       66     70       Acyl-CoA binding. {ECO:0000250}.
FT   REGION      151    322       ECH-like.
FT   REGION      198    202       Substrate binding.
FT                                {ECO:0000250|UniProtKB:Q05871}.
FT   MOTIF       392    394       Microbody targeting signal.
FT                                {ECO:0000255}.
FT   BINDING      92     92       Acyl-CoA. {ECO:0000250}.
FT   BINDING     111    111       Acyl-CoA. {ECO:0000250}.
FT   SITE        280    280       Important for catalytic activity.
FT                                {ECO:0000250|UniProtKB:Q05871}.
FT   MOD_RES      51     51       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      51     51       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   MOD_RES      55     55       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   MOD_RES      62     62       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   MOD_RES      62     62       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   MOD_RES      70     70       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   MOD_RES      81     81       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   MOD_RES      90     90       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   MOD_RES      92     92       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      92     92       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   MOD_RES     101    101       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     119    119       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     161    161       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   MOD_RES     289    289       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WUR2}.
FT   VAR_SEQ       1     35       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10354522,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_037854.
FT   VARIANT      47     47       M -> I (in dbSNP:rs3177253).
FT                                /FTId=VAR_058493.
FT   VARIANT     344    344       A -> V (in dbSNP:rs7166).
FT                                {ECO:0000269|PubMed:10354522,
FT                                ECO:0000269|PubMed:12097419}.
FT                                /FTId=VAR_058494.
FT   CONFLICT    119    119       S -> C (in Ref. 2; CAB66577).
FT                                {ECO:0000305}.
FT   CONFLICT    195    195       Y -> C (in Ref. 1; AAC19317).
FT                                {ECO:0000305}.
FT   HELIX        40     52       {ECO:0000244|PDB:2CQU}.
FT   HELIX        59     69       {ECO:0000244|PDB:2CQU}.
FT   TURN         70     74       {ECO:0000244|PDB:2CQU}.
FT   HELIX        87     99       {ECO:0000244|PDB:2CQU}.
FT   HELIX       104    118       {ECO:0000244|PDB:2CQU}.
FT   STRAND      140    147       {ECO:0000244|PDB:4U19}.
FT   STRAND      150    155       {ECO:0000244|PDB:4U19}.
FT   HELIX       158    160       {ECO:0000244|PDB:4U19}.
FT   HELIX       166    181       {ECO:0000244|PDB:4U19}.
FT   STRAND      185    192       {ECO:0000244|PDB:4U19}.
FT   HELIX       203    205       {ECO:0000244|PDB:2F6Q}.
FT   HELIX       212    232       {ECO:0000244|PDB:4U19}.
FT   STRAND      238    242       {ECO:0000244|PDB:4U19}.
FT   HELIX       249    252       {ECO:0000244|PDB:4U19}.
FT   HELIX       253    256       {ECO:0000244|PDB:4U19}.
FT   STRAND      258    263       {ECO:0000244|PDB:4U19}.
FT   STRAND      267    269       {ECO:0000244|PDB:4U19}.
FT   HELIX       273    275       {ECO:0000244|PDB:4U19}.
FT   HELIX       283    291       {ECO:0000244|PDB:4U19}.
FT   HELIX       293    300       {ECO:0000244|PDB:4U19}.
FT   STRAND      305    307       {ECO:0000244|PDB:4U18}.
FT   HELIX       308    313       {ECO:0000244|PDB:4U19}.
FT   STRAND      318    321       {ECO:0000244|PDB:4U19}.
FT   TURN        323    325       {ECO:0000244|PDB:4U19}.
FT   HELIX       326    337       {ECO:0000244|PDB:4U19}.
FT   HELIX       342    353       {ECO:0000244|PDB:4U19}.
FT   HELIX       354    356       {ECO:0000244|PDB:4U19}.
FT   HELIX       357    375       {ECO:0000244|PDB:4U19}.
FT   HELIX       378    383       {ECO:0000244|PDB:4U19}.
FT   HELIX       385    388       {ECO:0000244|PDB:4U19}.
SQ   SEQUENCE   394 AA;  43585 MW;  8AC633D43A320102 CRC64;
     MAMAYLAWRL ARRSCPSSLQ VTSFPVVQLH MNRTAMRASQ KDFENSMNQV KLLKKDPGNE
     VKLKLYALYK QATEGPCNMP KPGVFDLINK AKWDAWNALG SLPKEAARQN YVDLVSSLSP
     SLESSSQVEP GTDRKSTGFE TLVVTSEDGI TKIMFNRPKK KNAINTEMYH EIMRALKAAS
     KDDSIITVLT GNGDYYSSGN DLTNFTDIPP GGVEEKAKNN AVLLREFVGC FIDFPKPLIA
     VVNGPAVGIS VTLLGLFDAV YASDRATFHT PFSHLGQSPE GCSSYTFPKI MSPAKATEML
     IFGKKLTAGE ACAQGLVTEV FPDSTFQKEV WTRLKAFAKL PPNALRISKE VIRKREREKL
     HAVNAEECNV LQGRWLSDEC TNAVVNFLSR KSKL
//
